These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33310)

  • 21. Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
    Harrison DC
    Drugs; 1974; 7(1):1-7. PubMed ID: 4152164
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of beta blockaders in angina pectoris, myocardial infarct and functional heart diseases].
    Gerc V
    Med Arh; 1977; 31(2):77-80. PubMed ID: 20539
    [No Abstract]   [Full Text] [Related]  

  • 23. [Beta receptor blockers and calcium antagonists in coronary disease. Differential therapeutic aspects].
    Delius W
    Dtsch Med Wochenschr; 1983 Jul; 108(30):1154-8. PubMed ID: 6140156
    [No Abstract]   [Full Text] [Related]  

  • 24. [Beta blockers in ischemic cardiopathy].
    Cía Gómez P
    Rev Esp Cardiol; 1984; 37 Suppl 1():2-8. PubMed ID: 6150526
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta-blockers and myocardial infarction: infarction and ischaemia in the practolol and propranolol trials.
    Green KG; Baber NS; Lewis JA
    Aust N Z J Med; 1983 Apr; 13(2):181-2. PubMed ID: 6137206
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic administration of beta blocking agents: left ventricular hemodynamics in myocardial infarctions during exercise (author's transl)].
    Blümchen G; Esche HH
    Z Kardiol; 1981 Sep; 70(9):678-86. PubMed ID: 7303806
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical evaluation of adrenergic beta blocking agents in angina pectoris in a double blind trial].
    Saad EA; Prazeres PR; Siqueira PL; Amarante A; Levy S; Benchimol AB
    Arq Bras Cardiol; 1971 Feb; 24(1):7-16. PubMed ID: 4399358
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
    Prida XE; Feldman RL; Hill JA; Pepine CJ
    Am J Cardiol; 1987 Aug; 60(4):244-8. PubMed ID: 2887101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating effects of treatment in subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers.
    Yusuf S; Wittes J; Probstfield J
    Am J Cardiol; 1990 Jul; 66(2):220-2. PubMed ID: 1973589
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of beta-blockers during and after myocardial infarction.
    Aronow WS
    Compr Ther; 1998; 24(6-7):327-31. PubMed ID: 9669097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-adrenoceptor blockade in the treatment of coronary heart disease.
    Sleight P
    Eur Heart J; 1986 Dec; 7 Suppl C():79-91. PubMed ID: 2880717
    [No Abstract]   [Full Text] [Related]  

  • 33. [Beta adrenergic receptor blockaders in treatment of angina pectoris. A critical evaluation].
    Lukasik S; Wrabec K; Stańkowska K; Janicka K
    Pol Tyg Lek; 1973 Jan; 28(1):17-20. PubMed ID: 4405580
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of the action of beta-adrenergic blockers in the treatment of angina pectoris].
    de Mey D
    Acta Cardiol; 1972; ():Suppl 15:255-6. PubMed ID: 4147609
    [No Abstract]   [Full Text] [Related]  

  • 35. Exercise tolerance in patients with angina pectoris. Daily variation and effects of erythrityl tetranitrate, propranolol and alprenolol.
    Dagenais GR; Pitt B; Ross RS
    Am J Cardiol; 1971 Jul; 28(1):10-6. PubMed ID: 4397511
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparison of the action of beta-blockers and calcium inhibitors in the treatment of primary angina pectoris].
    Bory M; Bénichou M
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():153-9. PubMed ID: 6134506
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of beta-blockade on ST segment elevation after acute myocardial infarction in man with some experimental observations.
    Thomas M
    Acta Med Scand Suppl; 1976; 587():185-91. PubMed ID: 3097
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of tolamolol versus propranolol on systolic time intervals in angina.
    Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the treatment of angina pectoris with beta-blocking agents (Eraldin, Visken)].
    Mihail A; Popescu P; Ioan A; Bruckner I; Paraschiv A; Petrescu X; Popa N
    Med Interna (Bucur); 1973 Jan; 25(1):87-93. PubMed ID: 4144020
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of obsidan on the dynamics of the myocardial infarct zone in the 1st days of the disease].
    Ivanova LK
    Vrach Delo; 1980 Oct; (10):15-8. PubMed ID: 6108019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.